Introduction
In parotid acinar cells, stimulation of b-adrenergic receptors induces the exocytotic amylase release [1] . The amylase release is regulated by intracellular cAMP levels, since adenylate cyclase activators (such as forskolin), cAMP-phosphodiesterase inhibitors (such as 3-isobutyl-1-methylxanthine) and cell-permeable forms of cAMP (such as dibutylyl cAMP), mimic the effects of b-agonist on amylase release [2] [3] [4] . The amylase release occurs without elevation of intracellular calcium ion (Ca 2+ ) levels, because b-agonists provoke increases in intracellular cAMP levels, but have no effect on Ca 2+ levels [5, 6] .
In the cAMP-dependent amylase release, activation of cAMP-dependent protein kinase (PKA) is thought to be an essential step in the process. During amylase secretion from parotid acinar cells, the activity of PKA is enhanced [1] . PKA inhibitors inhibit the cAMP-dependent amylase release [7, 8] . Insertion of PKA induces amylase release in permeabilized parotid acinar cells [9] . Therefore, it seems likely that PKA phosphorylates proteins involved in amylase exocytosis. Several proteins have been reported to be phosphorylated following b-adrenergic stimulation in parotid glands [10] [11] [12] . However, it is not clear which protein is phosphorylated that is crucial for triggering the cAMP-dependent exocytosis.
On the other hand, it has also been thought that protein kinase C (PKC) activation is involved in amylase release in parotid acinar cells based on studies using PKC activators [13] [14] [15] . In this paper, we review the role and importance of PKC on the cAMP-dependent amylase release in parotid acinar cells. Summary It is well known that b-adrenergic receptor activation in parotid acinar cells results in increased intracellular cAMP levels, and consequently induces exocytotic amylase release. However, protein kinase C (PKC) has also been considered to contribute to amylase release. In this paper, we review the role of PKC in cAMP signaling and amylase release. PKCd, a so-called 'novel PKC', has been shown to be activated by b-adrenergic receptor stimulation. Myristoylated alanine-rich C kinase substrate (MARCKS), a major cellular substrate for PKC, is detected in parotid acinar cells, and MARCKS phosphorylation and translocation from the membrane to the cytosol are induced by b-adrenergic receptor stimulation. cAMP-dependent protein kinase (PKA) inhibitor inhibits b-agonist-induced PKC activation and MARCKS phosphorylation. The b-agonistinduced amylase release is inhibited by inhibitors of PKCd or by a MARCKS-related peptide. These findings suggest that MARCKS phosphorylation via PKCd activation, which is downstream of PKA activation, is involved in the cAMP-dependent amylase release in parotid acinar cells. # 2009 Japanese Association for Dental Science. Published by Elsevier Ireland. All rights reserved.
PKC in parotid acinar cells
PKCs comprise a family of phospholipid-dependent enzymes that catalyze the covalent transfer of phosphate from ATP to serine and threonine residues of proteins. PKCs are activated by a variety of extracellular signals and, in turn, modify the functions of many cellular proteins, including receptors, enzymes, cytoskeletal proteins and transcription factors. Phosphorylation of the substrate proteins induces conformational changes that modify their functional properties. Therefore, PKCs are involved in a large variety of cell functions and signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, ion fluxes, secretion and cell death [16] .
The PKC family consists of at least 10 members, which are divided into three subgroups based on their structural characteristics and cofactor requirements. They include the classical cPKC (a, bI, bII and g), the novel nPKC (d, e, h and u), and the atypical aPKC (z and i/l) isoforms [17, 18] . All isoforms require phosphatidylserine, a component of the phospholipid bilayer, for their activation. The classical cPKCs are Ca 2+ -sensitive and also require diacylglycerol (DAG) or tumor-promoting phorbol esters for their activation. The novel nPKCs are Ca 2+ -independent but still require DAG or phorbol esters [19] . The atypical aPKCs are also Ca 2+ -independent, and phosphatidylserine is sufficient for their maximal activity [20] . Thus, various stimuli can lead to different responses via isoform-specific PKC signaling regulated by their expression, localization and phosphorylation status in particular biological settings.
PKC activity was initially detected in rat parotid gland [21] . Subsequently, PKCa, d, e and z were found to be expressed in parotid acinar cells [22, 23] , and the involvement of PKC in amylase secretion in parotid acinar cells has been demonstrated [13] [14] [15] 21, 23] . The PKC activator phorbol esters, such as phorbol 12,13-dibutyrate and phorbol 12myristate 13-acetate (PMA), induce protein secretion in parotid gland slices [13] , and elicit amylase release in parotid acinar cells [14, 15] . It has been shown that phorbol esters have no effect on adenylate cyclase activity or Ca 2+ mobilization [13] . Those observations suggest that PKC contributes to amylase release in parotid acinar cells. However, the effects of PKC inhibitors vary; H7 inhibited amylase release induced by b-adrenergic receptor stimulation [21] , whereas Ro 31-8220 and CGP 41-251 enhances amylase release provoked by norephinephrine [23] .
Our current study [24] demonstrated that calphostin C, an inhibitor of DAG-sensitive PKC [25] , partially inhibits amylase release induced by b-adrenergic receptor stimulation. Since b-adrenergic receptor activation does not elicit Ca 2+ mobilization, this observation suggests that a Ca 2+ -independent and DAG-sensitive PKC, i.e. an nPKC such as PKCd, is involved in amylase release following b-adrenergic receptor stimulation. When the effect of the PKCd-specific inhibitor rottlerin was examined, that inhibitor mimicked the effect of calphostin C. It is known that activated isoforms of PKC, including PKCd, are phosphorylated and translocated from the cytosol to the cell membrane [26] . In parotid acinar cells stimulated with a b-agonist (isoproterenol), the amount of phosphorylated-PKCd in the membrane increased ( Fig. 1) , which strongly suggests that b-adrenergic receptor activation induces PKCd activation in parotid acinar cells. Taken together, it is most likely that PKCd activated by b-adrenergic receptor stimulation contributes to amylase release.
MARCKS in parotid acinar cells
Dozens of proteins that contain predicted phosphorylation sites for PKC have been identified. Myristoylated alanine-rich C kinase substrate (MARCKS) is a major cellular substrate for PKC [27] . MARCKS binds to the plasma membrane via the dual actions of a hydrophobically myristoylated N-terminus and a polybasic stretch within the so-called effecter domain [28] which is a phosphorylation site [29] . It is well known that phosphorylated MARCKS (p-MARCKS) translocates from the membrane to the cytosol, because phosphorylation of the effecter domain significantly decreases the binding force of MARCKS to the membrane [30] .
MARCKS has been implicated in various cellular functions [31, 32] . The involvement of MARCKS has been demonstrated in Ca 2+ -dependent secretory function. In chromaffin cells, PMA stimulates noradrenaline release and MARCKS phosphorylation, and a synthetic peptide of the phosphorylation site domain sequence of MARCKS inhibits the PMA-induced noradrenaline release in permeabilized cells [33, 34] . In insulinproducing INS-1 cells, glucagon-like peptide-1 (GLP-1) stimulates insulin secretion, PKCa and PKCe activation and MARCKS phosphorylation [35] . A PKC inhibitor inhibits MARCKS phosphorylation and insulin secretion coupled to GLP-1-stimulated signaling [35] . Prostaglandin F 2a (PGF 2a ) stimulates MARCKS phosphorylation and oxytocin secretion in bovine luteal cells [36] . However, PGF 2a failed to stimulate oxytocin exocytosis in cells expressing a mutant MARCKS which cannot be phosphorylated by PKC [36] . In SH-SY5Y human neuroblastoma cells, PMA elicits noradrenaline release and MARCKS phosphorylation [37] , and those effects could be abrogated by PKC inhibitors [37] . In BON human pancreatic carcinoid tumor cells, PMA provokes neurotensin secretion and MARCKS phosphorylation [38] . A small interfering RNA (siRNA) to MARCKS significantly reduces the PMAinduced neurotensin secretion, whereas over-expression of wild-type MARCKS clearly enhances that secretion. Furthermore, siRNAs to PKC inhibit the PMA-induced MARCKS phosphorylation [38] . These observations indicate that MARCKS phosphorylation is involved in Ca 2+ -dependent secretion. In NHBE normal human bronchial epithelial cells, a cholinergic agonist stimulated mucin secretion via cGMP signaling [39] . A myristoylated N-terminal sequence peptide of MARCKS (MANS) inhibited mucin secretion induced by 8-bromo-cGMP with PMA [39] or a cholinergic agonist [40, 41] . Therefore, it has also been suggested that MARCKS phosphorylation is involved in cGMP-dependent secretion.
Our recent observations demonstrate the involvement of MARCKS in cAMP signaling in parotid acinar cells [24] . The bagonist isoproterenol induces MARCKS phosphorylation in parotid acinar cells (Fig. 2 ). Since the adenylate cyclase activator forskolin and the membrane-permeable cAMP analog dibutyryl-cAMP also induce MARCKS phosphorylation, it is most likely that MARCKS phosphorylation is cAMP-dependent in parotid acinar cells. Unphosphorylated MARCKS binds to the cell membrane but its phosphorylation to p-MARCKS changes its localization from the membrane to the cytosol [30] . In fact, the amount of p-MARCKS in the cytosol increases in parotid acinar cells stimulated with the b-agonist isoproterenol (Fig. 3A) . Confocal microscopy reveals that MARCKS in the membrane disappears after stimulation with isoproterenol (Fig. 3B) . The PKA inhibitor H89 inhibits MARCKS phosphorylation induced by b-adrenergic receptor stimulation. These observations imply that MARCKS phosphorylation stimulated by b-adrenergic receptor activation is evoked via PKA activation in parotid acinar cells.
The relationship between MARCKS phosphorylation and PKC activity has been examined in parotid acinar cells. Inhibitors of several isoforms of PKC and of DAG-sensitive PKC (Gö6983 and calphostin C, respectively) inhibited MARCKS phosphorylation induced by b-adrenergic receptor stimulation, but an inhibitor of Ca 2+ -dependent PKC (Gö6976) had no effect. The PKCdspecific inhibitor rottlerin inhibited MARCKS phosphorylation. Since PKCd is activated by b-agonists as described above, it is most likely that the b-agonist-induced MARCKS phosphorylation is evoked by PKCd activation.
The involvement of MARCKS in the cAMP-dependent amylase release has also been examined in parotid acinar cells [24] . The N-terminal sequence peptide of MARCKS (MANS), has been shown to be a useful inhibitor of MARCKS function, because that peptide suppresses the secretory function of cultured cells [39] and in vivo [40, 41] . In parotid acinar cells preincubated with the MANS peptide, amylase release induced by a b-agonist was reduced, suggesting the involvement of MARCKS in amylase release.
How does MARCKS function?
We have described here that MARCKS phosphorylation by PKCd activation is downstream of PKA activation via b-adrenergic receptor activation, which is involved in amylase release in parotid acinar cells. However, it is not yet clear how p-MARCKS contributes to amylase release. Our hypothesis is that MARCKS is involved in regulating the actin cytoskeleton, because MARCKS has been proposed to function in the remodeling of the actin cytoskeleton through direct binding of F-actin [29] . Phosphorylation at the effecter domain dissociates MARCKS from F-actin [42] , and results in the loss of actin cross-linking and polymerization activity [29] . Moreover, a MARCKS effecter domain peptide has also been shown to induce rapid actin polymerization in vitro [43] . It has also been demonstrated that MARCKS phosphorylation by PKC causes MARCKS translocation from the membrane to the cytosol and also interferes with MARCKS binding to Factin in some types of cells such as chromaffin cells [33, 34] , luteal cells [36] and SH-SY5Y cells [37] . Such a regulation of the actin cytoskeleton is considered to allow the translocation of secretory vesicles from the cytosol to the membrane. In NHBE cells [39] , MARCKS has been suggested to function as a molecular linker by interacting with granule membranes at its N-terminal domain and binding to actin filaments at its effecter domain, thus tethering granules to the actin cytoskeleton allowing their movement and exocytosis.
Regarding the involvement of the actin cytoskeleton in exocytotic secretory function, regulation of the actin cytoskeleton structure is considered to be involved in exocytotic secretory function in chromaffin cells, because the actin network undergoes reorganization during regulated exocytosis [44] . In parotid acinar cells, since amylase release induced by b-adrenergic receptor stimulation is inhibited by the actin filament-disrupting reagent cytochalasin D [45] [46] [47] and by the actin stabilizing reagent jasplakinolide [47], regulation of the actin cytoskeleton has been suggested to be involved in amylase release. Therefore, it is conceivable that MARCKS phosphorylation plays an important role in the regulation of the actin cytoskeleton in the cAMP-dependent amylase release in parotid acinar cells, although further studies are needed to fully clarify this.
Conclusions
It is well known that b-adrenergic receptor stimulation induces increases in intracellular cAMP levels, subsequently activates PKA, which consequently results in exocytotic amylase release in parotid acinar cells. Our current observations show that PKA activates PKCd, which is involved in amylase release via MARCKS phosphorylation (Fig. 4) [24] . This implies crosstalk between the PKA and PKC signaling pathways. However, it is not yet clear how PKA activates PKCd in parotid acinar cells. PKCd has been reported to be regulated by several mechanisms such as the binding of DAG and the phosphorylation of tyrosine [48] . In parotid acinar cells, the involvement of phospholipase D, a DAG producing enzyme, in the cAMP-induced amylase release has been reported [49] . Furthermore, tyrosine phosphorylation in proteins has been reported to play a role in the process of amylase exocytosis [50] , and therefore, the contribution of these mechanisms to PKCd activation should be further studied.
